Market News & Trends
First on the Market: Safely Storing Deep-Cold Medications With Prefillable Polymer Syringes From SCHOTT Pharma
SCHOTT Pharma’s prefillable polymer syringes are a trailblazing solution for drug applications that need to be stored and transported on dry ice at temperatures approaching -100°C…..
Experic Adds Spray Drying Capabilities to Enhance Pharmaceutical Formulation & Development Services
Experic recently announced the addition of spray drying capabilities to support the formulation and development of biopharmaceuticals. The new spray drying services will be….
Bayer Receives Fast Track Designation for Asundexian Atrial Fibrillation Program
Bayer recently announced the US FDA has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment to prevent stroke and…
QSAM Biosciences & RLS Announce Clinical & Commercial Supply Agreement for Promising Clinical-Stage Metastatic & Primary Bone Cancer Treatment
QSAM Biosciences, Inc. and RLS (USA) Inc. recently announced a commercial supply and clinical dose preparation agreement for the therapeutic radiopharmaceutical drug candidate CycloSam (Samarium-153…
NurExone Granted US Patent for Technology & Drug Composition of Exo-PTEN, Designed for Treating Acute Spinal Cord Injuries
NurExone Biologic Inc. recently announced it has received an issue notification from the United States Patent and Trademark Office (USPTO) for US Patent NO. 11,648,260, granted for the period of 20 years from filing date until….
TILT Biotherapeutics Announces First Patient Dosed in Phase 1 Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination With Checkpoint Inhibitor
TILT Biotherapeutics recently announced the first patient has been dosed in a Phase 1 trial of the company’s oncolytic adenovirus TILT-123. The multi-centre open-label, Phase…
Empty Capsules Market is Expected to Reach $4.9 Billion
The empty capsules industry is poised for significant growth in the near future. With the rising demand for pharmaceutical and nutraceutical products, the market for…
First Wave BioPharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis
First Wave BioPharma, Inc. recently announced it has completed patient screening in its ongoing Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery…
SERB Pharmaceuticals & SFJ Pharmaceuticals Announce US Partnership for Ticagrelor Reversal Agent
SERB Pharmaceuticals and SFJ Pharmaceuticals recently announced SERB has acquired exclusive US rights to the ticagrelor reversal agent bentracimab from SFJ. Bentracimab is a novel,…
Cellular Origins Partners With ScaleReady to Simplify, Standardize & Automate Cell Therapy Manufacturing
Cellular Origins recently announced a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf that brings together process development expertise, tools, and technologies for scalable CGT….
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability With CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
Olema Pharmaceuticals, Inc. recently announced interim results from an ongoing Phase 1b/2 clinical study of OP-1250, the company’s complete estrogen receptor (ER) antagonist (CERAN) and…
Mekonos Announces Research Collaboration With bit.bio to Advance Cell Engineering
New collaboration combines Mekonos’ novel ex vivo delivery platform with bit.bio’s unique opti-ox™ precision cellular reprogramming technology to accelerate the development of human cells for research, drug discovery and….
Evonetix Delivers First Chip-Synthesized DNA to the University of Cambridge
Evonetix recently announced DNA synthesized using its unique semiconductor chip technology was delivered to the Department of Chemical Engineering and Biotechnology at the University of Cambridge. This milestone marks the start of the next stage of development of the….
Alvotech Enters Commercialization Agreement With Polifarma for Proposed Biosimilar to Eylea
Alvotech recently announced it has entered an exclusive agreement with Polifarma Ilac San. ve tic. A.S. for the commercialization in Turkey of AVT06, a proposed…
Syneos Health to be Acquired for Approximately $7.1 Billion
Syneos Health, Inc. recently announced it has entered into a definitive agreement to be acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital….
Minerva Neurosciences Announces Update on its NDA for the Treatment of Negative Symptoms in Schizophrenia
Minerva Neurosciences, Inc. recently announced that on May 8, 2023, it received confirmation from the US FDA that its New Drug Application (NDA) for roluperidone…
Salipro Biotech & DyNAbind Announce Milestone Achievement in Collaboration to Enable DEL for Membrane Proteins
The two biotech companies report that they have successfully screened and identified several small molecule compounds that bind to a challenging membrane protein drug target….
Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s INDA for the First Neoantigen-Directed T-Cell Therapy Product in Oncology
Adaptive Biotechnologies Corporation recently announced the US FDA has accepted an investigational new drug (IND) application submitted by its collaborator, Genentech, a member of the…
Longeveron Announces New Long-Term Survival Data From ELPIS I Trial of Lomecel-B for Hypoplastic Left Heart Syndrome
Longeveron Inc. recently announced new long-term follow-up data from the its ELPIS I trial of Lomecel-B for patients with hypoplastic left heart syndrome (HLHS). The…
Vetter Expands Production Capacities & Services at its Austrian Site
Vetter continues to drive the expansion of capacities and services for the provision of clinical trial materials. With the implementation of additional equipment for aseptic production and the expansion of storage….
